Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2005, Vol. 3 ›› Issue (6): 476-479.doi: 10.3736/jcim20050615

• Original Clinical Research • Previous Articles     Next Articles

Experimental study on effects of Shengmai Injection: enhancing 5-FU anti-tumor efficacy and reducing its toxicity

Zhen Chen,Peng Wang,Wen-xia Huang,Lu-ming Liu   

  1. Department of Traditional Chinese Medicine, Cancer Hospital, Fudan University, Shanghai 200032, China
  • Received:2004-12-20 Online:2005-11-20 Published:2005-11-20
  • Contact: Zhen CHEN


To observe the effects of Shengmai Injection on enhancing efficacy and reducing toxicity of 5-fluorouracil (5-FU).


Fifty hepatoma 22 bearing mice were randomly divided into five groups: control group, 5-Fu group, Shengmai Injection (low, medium and high dose) combined with 5-FU groups. There were 10 mice in each group. Mice in the five groups were injected introperitoneally the same amount of normal saline, 5-FU (20 mg·kg –1·d –1) and Shengmai Injection (3.5 ml·kg –1·d –1, 7 ml·kg –1·d –1 and 14 ml·kg –1·d –1) combined with 5-FU respectively, once a day for 14 days. After that, all mice were killed and the tumor inhibiting rates, index of immunological function, liver and kidney function and the blood cells in the peripheral blood were observed.


The tumor inhibiting rates were higher in each Shengmai Injection combined with 5-FU group than that in the 5-FU group (P<0.05). The levels of CD3, CD4, CD4/CD8, IgG, IgM in 5-FU group were lower (P<0.05), while those in the three Shengmai Injection combined with 5-FU groups were higher than those in the control group (P<0.05). The level of serum alanine aminotransferase (ALT) was higher and the WBC and PLT counts in the peripheral blood were lower in 5-FU group than those in the control group (P<0.05). But the levels of serum ALT in the three Shengmai Injection combined with 5-FU groups were consistent with that in the control group and the amounts of WBC decreased slightly.


Shengmai Injection can enhance the anti-tumor effect of 5-FU. It can also improve the immunological function and reduce the adverse reactions of chemotherapy.

Key words: Tumor inhibiting rates, Immunity, Adverse reaction, 5-Fluorouracil, Shengmai Injection

CLC Number: 

  • R73-36

Tab 1

Effect of Shengmai Injection on T-lymphocyte subgroups ($\bar{x}$±s )"

Group n CD3 (%) CD4 (%) CD8 (%) CD4/CD8
Control group 10 68.21±2.02 40.53±6.62 20.63±3.47 2.00±0.40
5-FU group 10 64.70±4.00* 34.78±4.06* 21.30±3.16 1.66±0.24*
High-dose Shengmai Injection + 5-FU group 10 70.17±1.33* 46.97±6.51* 17.80±2.03* 2.68±0.49*
Medium-dose Shengmai Injection + 5-FU group 10 71.69±3.55* 46.80±4.45* 16.92±2.99* 2.85±0.61*
Low-dose Shengmai Injection + 5-FU group 10 70.98±2.44* 46.77±4.14* 16.78±2.41* 2.84±0.52*

Tab 2

Effect of Shengmai Injection on humoral immune function ($\bar{x}$±s, g/L)"

Group n IgA IgG IgM
Control group 10 0.036±0.014 1.306±0.038 0.168±0.017
5-FU group 10 0.026±0.005 1.266±0.038* 0.151±0.012*
High-dose Shengmai Injection + 5-FU group 10 0.030±0.012 1.369±0.076* 0.188±0.019*
Medium-dose Shengmai Injection + 5-FU group 10 0.030±0.009 1.380±0.077* 0.184±0.014*
Low-dose Shengmai Injection + 5-FU group 10 0.031±0.009 1.351±0.037* 0.191±0.021*

Tab 3

Protective effect of Shengmai Injection on liver and renal function ($\bar{x}$±s )"

Group n ALT (U/L) Alb (g/L) BUN (mmol/L)
Control group 10 33.8±2.7 31.6±2.3 6.1±1.3
5-FU group 10 41.6±3.5* 30.6±2.9 7.0±0.4
High-dose Shengmai Injection + 5-FU group 10 35.8±2.6 30.5±1.5 6.5±0.6
Medium-dose Shengmai Injection + 5-FU group 10 35.0±8.0 31.3±2.9 6.2±0.9
Low-dose Shengmai Injection + 5-FU group 10 36.7±4.2 31.0±2.9 6.2±0.8

Tab 4

Effect of Shengmai Injection on peripheral blood cell count ($\bar{x}$±s )"

Group n WBC (×109/L) Hb (g/L) PLT (×109/L)
Control group 10 6.4±2.0 117.8±11.0 68.7±7.0
5-FU group 10 3.6±1.3* 107.9±11.0 56.3±10.5*
High-dose Shengmai Injection+5-FU group 10 4.6±0.4 112.0±14.0 66.2±7.0
Medium-dose Shengmai Injection+5-FU group 10 4.6±0.5 109.2±14.2 66.1±7.5
Low-dose Shengmai Injection+5-FU group 10 4.8±0.6 112.4±11.3 65.9±7.7
[1] 张代钊, 于尔辛, 余桂清 . 中医药对肿瘤放化疗的增敏减毒作用[J]. 中国中西医结合杂志, 1992,12(3):135-138
[2] 于尔辛 . 中药扶正培本在恶性肿瘤治疗方面的应用[J]. 医学理论与实践, 1994,7(8):21-23
[3] 刘鲁明 . 新世纪中医药及中西医结合抗肿瘤研究展望[J]. 浙江中西医结合杂志, 2002,12(4):203-205
[4] 杜丽华, 邓学瑞, 张才军 , 等. 生脉注射液对小鼠免疫功能的影响[J]. 上海免疫学杂志, 2001,21(4):247-249
[5] 姚春莜 . 生脉注射液防治放射性肺损伤96例疗效分析[J]. 中华放射医学与防护杂志, 2004,24(1):52-53
[6] Kastelan Z, Lukac J, Derezic D , et al. Lymphocyte subsets, lymphocyte reactivity to mitogens, NK cell activity and neutrophil and monocyte phagocytic functions in patients with bladder carcinoma[J]. Anticancer Res, 2003,23(6D):5185-5189
[7] Van Sandick JW, Boermeester MA, Gisbertz SS , et al. Lymphocyte subsets and T(h)1/T(h)2 immune responses in patients with adenocarcinoma of the oesophagus or oesophagogastric junction: relation to pTNM stage and clinical outcome[J]. Cancer Immunol Immunother, 2003,52(10):617-624
doi: 10.1007/s00262-003-0406-7
[8] Hadden JW . Immunodeficiency and cancer: prospects for correction[J]. Int Immunopharmacol, 2003,3(8):1061-1071
doi: 10.1016/S1567-5769(03)00060-2
[9] 许志良, 刘永林, 俞颖 . 肿瘤患者CD4/CD8、γδT细胞化疗前后的变化[J]. 中国预防医学杂志, 2004,4(5):140-141
[10] Diederichsen AC, Hjelmborg JB, Christensen PB , et al. Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells[J]. Cancer Immunol Immunother, 2003,52(7):423-428
doi: 10.1007/s00262-003-0388-5
[11] 韦红 . 生脉饮对肺癌化疗患者免疫扶正临床观察[J]. 中医药研究, 2002,18(5):19-20
[1] Yu-fangLin, Zhi-danLiu, WenMa, Wei-dongShen. Hazards of insomnia and the effects of acupuncture treatment on insomnia. Journal of Integrative Medicine, 2016, 14(3): 174-186.
[2] Su-fang Zhang, Chang-quan Ling , Bai Li, Hong-yun Chen , Zhe Chen. Effects of Sisheng Decoction on the immunity and anti-stress function in mice with spleen deficiency syndrome. Journal of Chinese Integrative Medicine, 2012, 10(12): 1465-1469.
[3] Ai-ming Wu, Dong-mei Zhang, Li-xia Lou, Jian-ying Zhai, Xi-ying Lü, Li-min Chai, Shuo-ren Wang. Effects of Chinese herbal medicines Shengmai injection and Xuesaitong injection on ventricular fibrillation threshold and connexin 43 expression in rats with myocardial infarction. Journal of Chinese Integrative Medicine, 2011, 9(7): 775-782.
[4] Zhu-ye Gao, Hao Xu, Ke-ji Chen, Da-zhuo Shi, Li-zhi Li, Xue-zhong Zhou. Efficacy evaluation of Shengmai Injection in treating coronary heart disease based on random walk model. Journal of Chinese Integrative Medicine, 2008, 6(9): 902-906.
[5] Zhi-jun Dai, Xi-jing Wang, Zong-zheng Ji, Zong-fang Li, Wei Tang, Hua-feng Kang, Xiao-bin Ma, Lei Liu. Scutellaria barbata extract enhances efficacy and reduces toxicity of chemotherapy in hepatoma H22-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(7): 720-724.
[6] Qi Wang, Shi-lin Yao, Jing Dong, Hong-dong Wu, Cheng-yu Wu, Zhong-yuan Xia, He-feng Shi, Guo-ming Pan, Qi-wei Pan, Jian-xiong Zhao, Jing Cai, Zheng-zhi Cui. Changes of endocrine and immune function in subjects of yang deficiency constitution. Journal of Chinese Integrative Medicine, 2008, 6(12): 1226-1232.
[7] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82.
[8] Wei Gu, Ya-ni Zhang, Bai Li, Jie Han, Bin-bin Cheng, Chang-quan Ling. Establishment of a multidrug-resistant cell line BEL-7402/5-FU of human hepatocellular carcinoma and its biological characteristics. Journal of Chinese Integrative Medicine, 2006, 4(3): 265-270.
[9] Fu-feng Li, Guo-gang Li, You-zhong Wu, Jing Li, Xiao-ying Zhang, Hui-fang Wang, Yi-qin Wang. Immunological mechanism of exfoliative tongue fur in children with asthma. Journal of Chinese Integrative Medicine, 2005, 3(6): 446-449.
[10] Le-hong Jin, Chuan-fei Liu, Yu Zeng. Protective effects of puerarin on radiation injury of experimental rats. Journal of Chinese Integrative Medicine, 2005, 3(1): 43-45.
[11] You-qi Xu, Hui-ning Xue, Xiao-qiu Zhu, Xiao-dong Chen. Clinical observation on treatment for postoperative metastasis of gastric cancer by Jianpi Huoxue Jiedu prescription. Journal of Chinese Integrative Medicine, 2003, 1(3): 192-194.
Full text



[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[5] . Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication (Chinese version, part two). Journal of Chinese Integrative Medicine, 2010, 8(11): 1001-1005
[6] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7] Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[8] Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[9] Rui Jin, Bing Zhang. A complexity analysis of Chinese herbal property theory: the multiple formations of herbal property (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(11): 1198-1205
[10] Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228